ATE344675T1 - Verwendung eines betablockers zur behandlung von atherosklerose - Google Patents
Verwendung eines betablockers zur behandlung von atheroskleroseInfo
- Publication number
- ATE344675T1 ATE344675T1 AT01941409T AT01941409T ATE344675T1 AT E344675 T1 ATE344675 T1 AT E344675T1 AT 01941409 T AT01941409 T AT 01941409T AT 01941409 T AT01941409 T AT 01941409T AT E344675 T1 ATE344675 T1 AT E344675T1
- Authority
- AT
- Austria
- Prior art keywords
- beta blocker
- treat atherosclerosis
- atherosclerosis
- treat
- blocker
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002354A SE0002354D0 (sv) | 2000-06-22 | 2000-06-22 | New formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE344675T1 true ATE344675T1 (de) | 2006-11-15 |
Family
ID=20280209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01941409T ATE344675T1 (de) | 2000-06-22 | 2001-06-15 | Verwendung eines betablockers zur behandlung von atherosklerose |
Country Status (28)
Country | Link |
---|---|
US (2) | US20030191177A1 (de) |
EP (1) | EP1296716B1 (de) |
JP (1) | JP2003535875A (de) |
KR (1) | KR20030010750A (de) |
CN (1) | CN1437484A (de) |
AR (1) | AR028699A1 (de) |
AT (1) | ATE344675T1 (de) |
AU (1) | AU2001274766A1 (de) |
BG (1) | BG107373A (de) |
BR (1) | BR0111790A (de) |
CA (1) | CA2411100A1 (de) |
CZ (1) | CZ20024181A3 (de) |
DE (1) | DE60124400T2 (de) |
EE (1) | EE200200703A (de) |
ES (1) | ES2274892T3 (de) |
HK (1) | HK1054508A1 (de) |
HU (1) | HUP0302371A3 (de) |
IL (1) | IL153245A0 (de) |
IS (1) | IS6653A (de) |
MX (1) | MXPA02012957A (de) |
NO (1) | NO20026177L (de) |
NZ (1) | NZ523188A (de) |
PL (1) | PL360484A1 (de) |
RU (1) | RU2271802C2 (de) |
SE (1) | SE0002354D0 (de) |
SK (1) | SK18072002A3 (de) |
WO (1) | WO2001097751A2 (de) |
ZA (1) | ZA200209908B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005053683A1 (en) | 2003-11-26 | 2005-06-16 | Duke University | A method of preventing or treating glaucoma |
KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 a 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
KR100836321B1 (ko) | 2006-10-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 모니터 장치 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175187A (en) * | 1989-03-06 | 1992-12-29 | Soorianarain Baligadoo | Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
US5455269A (en) * | 1989-03-06 | 1995-10-03 | Baligadoo; Soorianarain | Synergistic compositions of amiodarone and beta blockers |
EP0576617B1 (de) * | 1991-03-18 | 1996-08-07 | Sepracor, Inc. | Zubereitung und verfahren enthaltend optisch reines s-metoprolol |
JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
NO177455C (no) * | 1993-06-04 | 1995-09-20 | Gerrit Elmenhorst | Anordning ved apparat for fremstilling av brannslukkende skum |
AU732465B2 (en) * | 1996-04-17 | 2001-04-26 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
SE9602762D0 (sv) * | 1996-07-12 | 1996-07-12 | Astra Ab | Carton and blank for forming the same |
US5998458A (en) * | 1997-06-25 | 1999-12-07 | University Technology Corporation | Method of treating heart failure |
GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
AU779264B2 (en) * | 1998-12-23 | 2005-01-13 | G.D. Searle Llc | Combinations for cardiovascular indications |
-
2000
- 2000-06-22 SE SE0002354A patent/SE0002354D0/xx unknown
-
2001
- 2001-06-11 AR ARP010102759A patent/AR028699A1/es not_active Application Discontinuation
- 2001-06-15 CA CA002411100A patent/CA2411100A1/en not_active Abandoned
- 2001-06-15 PL PL36048401A patent/PL360484A1/xx not_active Application Discontinuation
- 2001-06-15 HU HU0302371A patent/HUP0302371A3/hu unknown
- 2001-06-15 CZ CZ20024181A patent/CZ20024181A3/cs unknown
- 2001-06-15 WO PCT/SE2001/001380 patent/WO2001097751A2/en not_active Application Discontinuation
- 2001-06-15 CN CN01811540A patent/CN1437484A/zh active Pending
- 2001-06-15 EE EEP200200703A patent/EE200200703A/xx unknown
- 2001-06-15 SK SK1807-2002A patent/SK18072002A3/sk unknown
- 2001-06-15 DE DE60124400T patent/DE60124400T2/de not_active Expired - Fee Related
- 2001-06-15 AU AU2001274766A patent/AU2001274766A1/en not_active Abandoned
- 2001-06-15 EP EP01941409A patent/EP1296716B1/de not_active Expired - Lifetime
- 2001-06-15 US US10/311,201 patent/US20030191177A1/en not_active Abandoned
- 2001-06-15 RU RU2002133205/15A patent/RU2271802C2/ru not_active IP Right Cessation
- 2001-06-15 NZ NZ523188A patent/NZ523188A/en unknown
- 2001-06-15 AT AT01941409T patent/ATE344675T1/de not_active IP Right Cessation
- 2001-06-15 JP JP2002503228A patent/JP2003535875A/ja active Pending
- 2001-06-15 KR KR1020027017474A patent/KR20030010750A/ko not_active Application Discontinuation
- 2001-06-15 BR BR0111790-4A patent/BR0111790A/pt not_active IP Right Cessation
- 2001-06-15 MX MXPA02012957A patent/MXPA02012957A/es unknown
- 2001-06-15 IL IL15324501A patent/IL153245A0/xx unknown
- 2001-06-15 ES ES01941409T patent/ES2274892T3/es not_active Expired - Lifetime
-
2002
- 2002-12-05 ZA ZA200209908A patent/ZA200209908B/en unknown
- 2002-12-11 BG BG107373A patent/BG107373A/bg unknown
- 2002-12-11 IS IS6653A patent/IS6653A/is unknown
- 2002-12-20 NO NO20026177A patent/NO20026177L/no not_active Application Discontinuation
-
2003
- 2003-09-22 HK HK03106811.1A patent/HK1054508A1/zh unknown
-
2006
- 2006-04-19 US US11/407,505 patent/US20060252814A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060252814A1 (en) | 2006-11-09 |
WO2001097751A3 (en) | 2002-03-28 |
CZ20024181A3 (cs) | 2003-04-16 |
DE60124400T2 (de) | 2007-10-31 |
US20030191177A1 (en) | 2003-10-09 |
JP2003535875A (ja) | 2003-12-02 |
SE0002354D0 (sv) | 2000-06-22 |
IL153245A0 (en) | 2003-07-06 |
NZ523188A (en) | 2006-06-30 |
SK18072002A3 (sk) | 2003-08-05 |
BG107373A (bg) | 2003-09-30 |
CA2411100A1 (en) | 2001-12-27 |
EE200200703A (et) | 2004-08-16 |
NO20026177D0 (no) | 2002-12-20 |
IS6653A (is) | 2002-12-11 |
ES2274892T3 (es) | 2007-06-01 |
HK1054508A1 (zh) | 2003-12-05 |
KR20030010750A (ko) | 2003-02-05 |
MXPA02012957A (es) | 2003-05-15 |
AR028699A1 (es) | 2003-05-21 |
ZA200209908B (en) | 2004-03-05 |
PL360484A1 (en) | 2004-09-06 |
DE60124400D1 (de) | 2006-12-21 |
WO2001097751A2 (en) | 2001-12-27 |
CN1437484A (zh) | 2003-08-20 |
HUP0302371A2 (hu) | 2003-11-28 |
NO20026177L (no) | 2002-12-20 |
BR0111790A (pt) | 2003-05-20 |
HUP0302371A3 (en) | 2007-03-28 |
RU2271802C2 (ru) | 2006-03-20 |
EP1296716A2 (de) | 2003-04-02 |
EP1296716B1 (de) | 2006-11-08 |
AU2001274766A1 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69826110D1 (de) | Medizinische vorrichtung zur behandlung einer beschädigung einer anatomischen leitung | |
DE69910781D1 (de) | Behandlung zur beseitigung von gerüchen | |
ATE259245T1 (de) | Verfahren zur behandlung von beweggungsstörungen | |
DE60103137D1 (de) | Impstoff zur behandlung von atherosclerosis | |
ATE365042T1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
DE60100851D1 (de) | Piperidin verbindung zur behandlung von psoriasis | |
ATE353218T1 (de) | Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis | |
DE60112435D1 (de) | Vorrichtung zur behandlung von abfällen | |
ATE307920T1 (de) | Verfahren zur antimikrobiellen behandlung von fasermaterialien | |
DE60101309D1 (de) | Diacerein zur behandlung von psoriasis | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
ATE339955T1 (de) | Verwendung von escitalopram zur behandlung von generalisierten angstzuständen | |
ATE232378T1 (de) | Reinigungspflaster zur verbesserung des hautzustandes | |
ATE494069T1 (de) | Verfahren zur aufbereitung von shredder- rückständen zur erzeugung einer granulat-fraktion | |
DE60104791D1 (de) | Cyclobutendion-Derivate zur Behandlung von Artherosclerose | |
ATE410181T1 (de) | Verwendung von intereferon gamma zur behandlung von herzhypertrophie | |
ATE344675T1 (de) | Verwendung eines betablockers zur behandlung von atherosklerose | |
ATA9782000A (de) | Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen | |
ATE317261T1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
DE60103503D1 (de) | Verwendung von fsh zur behandlung von infertilität | |
ATE274044T1 (de) | Zusammensetzungen zur behandlung von gewebe | |
ATE270545T1 (de) | Verwendung von nmda antagonisten zur behandlung des reizkolons | |
DE60016755D1 (de) | Verfahren zur behandlung von rohöl | |
ATE255892T1 (de) | Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa | |
ATE336246T1 (de) | Verfahren zur behandlung von neurodegeneration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |